Phase 2, dose-ranging study of vupanorsen in patients with diabetes, hepatic steatosis and hypertriglyceridaemia

Educational partners and supporters (others pending)

Akcea Ionis logo 2021
Amarin Logo
Kowa Logo
Pfizer Logo